Multiple system atrophy: the putative causative role of environmental toxins.

BACKGROUND Whereas a number of studies have investigated the putative role of environmental toxins in the pathogenesis of idiopathic Parkinson disease, the possibility of such a role in multiple system atrophy has received little attention. DESIGN AND SETTING Review of records of patients examined in the Parkinson's Disease Center and Movement Disorder Clinic, Baylor College of Medicine, Houston, Tex, from July 1, 1977, to February 4, 1998. PATIENTS We reviewed 100 consecutive medical records of patients who satisfied the diagnostic criteria for multiple system atrophy formulated by the Consensus Committee of the American Autonomic Society and the American Academy of Neurology. INTERVENTION The type and amount of toxin exposure were verified by history and examination of records whenever possible. Severity of parkinsonism was assessed by clinical rating scales. MAIN OUTCOME MEASURE Development of multiple system atrophy after environmental toxin exposure. RESULTS Eleven patients had a notable history of heavy exposure to environmental toxins. One patient with multiple system atrophy confirmed by postmortem evaluation was exposed to high concentrations of malathion, diazinon, and formaldehyde, while the other patients with multiple system atrophy had well-documented high exposures to agents including n-hexane, benzene, methyl isobutyl ketone, and pesticides. The case studied pathologically demonstrated extensive advanced glial changes, including glial cytoplasmic inclusions in deep cerebellar white matter, brainstem, cortex (superior frontal, insula) and putamen, with notable cell loss and depigmentation of the substantia nigra and locus ceruleus. CONCLUSION While many studies report a possible role of environmental toxins in Parkinson disease, such a role is even more likely in multiple system atrophy, as this is a sporadic disease.

[1]  Y. Lolin Chronic Neurological Toxicity Associated with Exposure to Volatile Substances , 1989, Human toxicology.

[2]  C. Goetz,et al.  Neurotoxins in Clinical Practice , 1986 .

[3]  Roberta F. White,et al.  Solvents and neurotoxicity , 1997, The Lancet.

[4]  C. Tanner,et al.  Environmental Factors in the Etiology of Parkinson's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[5]  R. Roth,et al.  3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated parkinsonism , 1989, Experimental Neurology.

[6]  J. Langston,et al.  An electron microscopic study of MPTP-induced inclusion bodies in an old monkey , 1988, Brain Research.

[7]  K. Rabheru,et al.  Four Cases of Progressive Supranuclear Palsy in Patients Exposed to Organic Solvents* , 1989, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[8]  P. Brundin,et al.  Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionate , 1996, Neuroscience.

[9]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[10]  I. Mitchell,et al.  Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus , 1985, Neuroscience Letters.

[11]  N. P. Quinn,et al.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy , 1996, Neurology.

[12]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[13]  C. Tanner,et al.  Do environmental toxins cause Parkinson's disease? A critical review , 1990, Neurology.

[14]  J W Langston,et al.  Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys , 1986, Annals of neurology.

[15]  M. O’Malley Clinical evaluation of pesticide exposure and poisonings , 1997, The Lancet.

[16]  P. Lantos,et al.  Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy , 1992, Journal of the Neurological Sciences.

[17]  T. Révész,et al.  Glial cytoplasmic inclusions are not exclusive to multiple system atrophy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[18]  Y. Agid,et al.  Clinical and pathological features in hydrocarbon‐induced Parkinsonism , 1996, Annals of neurology.

[19]  Sid Gilman,et al.  Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions , 1996, Annals of neurology.

[20]  H U Rehman,et al.  Multiple system atrophy , 2001, Postgraduate medical journal.

[21]  S. Ho,et al.  Epidemiologic study of Parkinson's disease in Hong Kong , 1989, Neurology.

[22]  H. Yamaguchi,et al.  Oligodendroglial Microtubular Tangles in Olivopontocerebellar Atrophy , 1990, Journal of neuropathology and experimental neurology.

[23]  P. Lantos,et al.  The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. , 1994, Brain : a journal of neurology.

[24]  J. Langston,et al.  Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+ , 1987, Neuroscience Letters.

[25]  C. E. Becker Methanol poisoning. , 1983, The Journal of emergency medicine.

[26]  R. Uitti,et al.  Geography, Drinking Water Chemistry, Pesticides and Herbicides and the Etiology of Parkinson's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[27]  C. Rebert,et al.  Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey , 1984, Brain Research.

[28]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. W. Olanow,et al.  Manganese intoxication in the rhesus monkey , 1996, Neurology.